These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3302693)

  • 1. Experience with mutagenicity testing of new drugs: viewpoint of a regulatory agency.
    Madle S; Korte A; Bass R
    Mutat Res; 1987 Aug; 182(4):187-92. PubMed ID: 3302693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quality of genotoxicity testing of drugs. Experiences of a regulatory agency with new and old compounds.
    Müller L; Kasper P; Madle S
    Mutagenesis; 1991 Mar; 6(2):143-9. PubMed ID: 2056916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity test schemes and guidelines: U.S. EPA Office of Pollution Prevention and Toxics and Office of Pesticide Programs.
    Auletta AE; Dearfield KL; Cimino MC
    Environ Mol Mutagen; 1993; 21(1):38-45; discussion 46-57. PubMed ID: 8419153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic toxicology testing requirements: official and unofficial views from Europe.
    Kirkland DJ
    Environ Mol Mutagen; 1993; 21(1):8-14; discussion 46-57. PubMed ID: 8419157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Miniscreen assay to screen novel compounds for bacterial mutagenicity in the pharmaceutical industry.
    Burke DA; Wedd DJ; Burlinson B
    Mutagenesis; 1996 Mar; 11(2):201-5. PubMed ID: 8671739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
    Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
    Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative study of mutagenicity with Salmonella typhimurium TA102.
    Jung R; Engelhart G; Herbolt B; Jäckh R; Müller W
    Mutat Res; 1992 Apr; 278(4):265-70. PubMed ID: 1373863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay.
    Morimoto I; Watanabe F; Osawa T; Okitsu T; Kada T
    Mutat Res; 1982 Apr; 97(2):81-102. PubMed ID: 6804865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical purity and mutagenicity: case study of a drug in development.
    Kropko ML; Jaen JC; Theiss JC; Wold S; Caprathe BW; Wise LD
    Mutat Res; 1992 Apr; 281(4):233-8. PubMed ID: 1373215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicity.
    Dearfield KL; Auletta AE; Cimino MC; Moore MM
    Mutat Res; 1991 Nov; 258(3):259-83. PubMed ID: 1719404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames test.
    Harding AP; Popelier PL; Harvey J; Giddings A; Foster G; Kranz M
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):244-50. PubMed ID: 25542092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Workshop on Standardisation of Genotoxicity Test Procedures. Summary of major conclusions.
    Kirkland DJ; Galloway SM; Sofuni T
    Mutat Res; 1994 Jun; 312(3):205-9. PubMed ID: 7514734
    [No Abstract]   [Full Text] [Related]  

  • 13. Japanese guidelines for mutagenicity testing. Ministry of Agriculture, Forestry and Fisheries; Ministry of Health and Welfare; Ministry of Labor.
    Sofuni T
    Environ Mol Mutagen; 1993; 21(1):2-7; discussion 46-57. PubMed ID: 8419152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals.
    Müller L; Kasper P
    Mutat Res; 2000 Jan; 464(1):19-34. PubMed ID: 10633174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Draft guidelines on mutagenicity testing of new drugs issued by the CPMP. A four test screen.
    Draper MH; Griffin JP
    Arch Toxicol; 1980 Nov; 46(1-2):9-19. PubMed ID: 7236001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity tests for new chemicals in Germany: routine in vitro test systems.
    Broschinski L; Madle S; Hensel C
    Mutat Res; 1998 Oct; 418(2-3):121-9. PubMed ID: 9757015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems concerned with microbial mutagenicity tests].
    Gericke D
    Onkologie; 1982 Feb; 5(1):30-2, 34-5. PubMed ID: 6461834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity tests. Considerations regarding the selection of a standard battery test.
    Shimada H
    J Toxicol Sci; 1996 Dec; 21(5):469-72. PubMed ID: 9035056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.